Integra LifeSciences Holdings Corporation
DE ˙ DB ˙ US4579852082
13,30 € ↓ -0,40 (-2,92%)
2026-06-02
DEL PRIS
SecurityDE:IL3 / Integra LifeSciences Holdings Corporation
InstitutionMorgan Stanley
Latest Disclosed Ownership3,379,401 shares
Ownership 4.30%
Morgan Stanley ownership in IL3 / Integra LifeSciences Holdings Corporation

2025-08-05 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,379,401 shares of Integra LifeSciences Holdings Corporation (DE:IL3). This represents 4.3 percent ownership of the company. In their previous filing dated 2024-02-09 , Morgan Stanley had reported owning 4,634,346 shares, indicating a decrease of -27.08 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2025-08-05 2025-08-05 13G/A 4,634,346 3,379,401 -27.08 4.30 -27.12
2024-02-09 2024-02-09 13G/A 5,681,483 4,634,346 -18.43 5.90 -13.24
2023-02-09 2023-02-09 13G/A 5,361,471 5,681,483 5.97 6.80 7.94
2022-02-11 2022-02-11 13G 5,361,471 6.30

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,584,155 -264,912 -6.88 33,763 -29.38 0.0020
2026-05-27 2025-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,849,067 24,404 0.64 47,805 -12.78 0.0029
2026-02-13 2025-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,849,067 24,404 47,805 0.0029
2026-05-27 2025-09-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,824,663 -109,347 -2.78 54,807 13.54 0.0033
2025-11-14 2025-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,824,663 -109,347 54,807 0.0033
2025-08-15 2025-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 3,934,010 -876,770 -18.23 48,270 -54.37 0.0031
2025-05-15 2025-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,810,780 -510,463 -9.59 105,789 -12.34 0.0076
2025-05-15 2024-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,321,243 64,887 1.23 120,686 26.36 0.0085
2025-02-14 2024-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,321,243 64,887 120,686 0.0085
2025-05-14 2024-09-30 13F/A-2 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,256,356 -242,171 -4.40 95,508 -40.39 0.0069
2025-02-14 2024-09-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,256,356 -242,171 95,508 0.0069
2024-11-14 2024-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,256,356 -242,171 95,508 0.0008
2025-05-14 2024-06-30 13F/A-2 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,498,527 583,984 11.88 160,227 -8.03 0.0124
2024-10-17 2024-06-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,498,527 583,984 160,227 0.0124
2024-08-14 2024-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,498,527 583,984 160,227 0.0124
2024-10-17 2024-03-31 13F/A-2 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,914,543 -356,154 -6.76 174,221 -24.10 0.0140
2024-08-16 2024-03-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,914,543 -356,154 174,221 0.0140
2024-05-15 2024-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 4,914,543 -356,154 174,221 0.0140
2024-08-16 2023-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,270,697 -677,945 -11.40 229,539 1.04 0.0202
2024-02-13 2023-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,270,697 -677,945 229,539 0.0202
2023-11-15 2023-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 5,948,642 -307,361 -4.91 227,179 -11.71 0.0231
2023-08-14 2023-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 6,256,003 -317,007 -4.82 257,309 -31.81 0.0254
2023-05-15 2023-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 6,573,010 276,245 4.39 377,357 6.88 0.0405
2023-02-14 2022-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 6,296,765 5,372,602 581.35 353,060 801.88 0.0401
2022-11-14 2022-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 924,163 40,328 4.56 39,147 -18.02 0.0053
2022-10-27 2022-06-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 883,835 161,612 22.38 47,754 2.89 0.0062
2022-08-15 2022-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 883,835 161,612 47,754 0.0012
2022-10-27 2022-03-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 722,223 64,315 9.78 46,411 5.30 0.0063
2022-05-13 2022-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 722,223 64,315 46,411 0.0063
2022-02-14 2021-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 657,908 -75,960 -10.35 44,073 -12.30 0.0054
2021-11-15 2021-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 733,868 203,824 38.45 50,254 38.94 0.0068
2021-08-23 2021-06-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 530,044 73,317 16.05 36,169 14.62 0.0048
2021-08-16 2021-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 530,044 73,317 36,169 0.0010
2021-05-17 2021-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 456,727 -18,102 -3.81 31,556 2.37 0.0046
2021-02-16 2020-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 474,829 79,336 20.06 30,826 65.07 0.0048
2020-11-13 2020-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 395,493 12,060 3.15 18,674 3.65 0.0036
2020-08-14 2020-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 383,433 6,652 1.77 18,017 7.05 0.0040
2020-05-26 2020-03-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 376,781 252,381 202.88 16,831 132.15 0.0046
2020-05-15 2020-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 376,781 252,381 16,831 1,292.9717
2020-02-14 2019-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 124,400 20,698 19.96 7,250 16.39 0.0017
2019-11-14 2019-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 103,702 76,400 279.83 6,229 308.73 0.0016
2019-08-14 2019-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 27,302 -4,644 -14.54 1,524 -14.38 0.0004
2019-05-15 2019-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 31,946 -194,831 -85.91 1,780 -82.60 0.0005
2019-02-14 2018-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 226,777 132,753 141.19 10,227 65.14 0.0031
2019-04-23 2018-09-30 13F/A-2 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 94,024 -63,011 -40.13 6,193 -38.78 0.0016
2018-11-20 2018-09-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 94,024 0 6,193 0.0016
2018-11-14 2018-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 94,024 -63,011 6,193
2019-04-23 2018-06-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 157,035 -8,742 -5.27 10,116 10.27 0.0027
2018-08-14 2018-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 157,035 -8,742 10,116
2019-04-23 2018-03-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 165,777 5,123 3.19 9,174 19.31 0.0025
2018-05-14 2018-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 165,777 5,123 9,174
2019-04-23 2017-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 160,654 49,866 45.01 7,689 37.50 0.0021
2018-02-14 2017-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 160,654 49,866 7,689
2017-11-14 2017-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 110,788 31,561 39.84 5,592 29.50 0.0017
2017-08-11 2017-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 79,227 -265,271 -77.00 4,318 -70.25 0.0013
2017-05-22 2017-03-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 344,498 244,162 243.34 14,513 68.62 0.0045
2017-05-12 2017-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 344,498 14,513
2017-02-22 2016-12-31 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 100,336 10,629 11.85 8,607 16.23 0.0028
2017-02-13 2016-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 100,336 8,607
2016-11-10 2016-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 89,707 70,923 377.57 7,405 394.66 0.0025
2016-08-12 2016-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 18,784 -69,103 -78.63 1,497 -74.71 0.0005
2016-05-12 2016-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 87,887 69,841 387.02 5,920 384.06 0.0023
2016-02-09 2015-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 18,046 3,970 28.20 1,223 45.94 0.0004
2016-02-08 2015-09-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 14,076 -22,931 -61.96 838 -66.40 0.0003
2015-11-09 2015-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 14,076 838
2015-08-12 2015-06-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 37,007 15,533 72.33 2,494 88.37 0.0009
2015-05-14 2015-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 21,474 -865 -3.87 1,324 9.33 0.0005
2015-02-13 2014-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 22,339 4,303 23.86 1,211 35.31 0.0004
2014-12-16 2014-09-30 13F/A-1 INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 18,036 -8,461 -31.93 895 -26.64 0.0003
2014-11-14 2014-09-30 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 18,036 895
2014-05-13 2014-03-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 26,497 16,884 175.64 1,220 165.80 0.0005
2014-02-13 2013-12-31 13F INTEGRA LIFESCIENCES HLDGS C COM NEW 457985208 9,613 -949 -8.99 459 8.00 0.0002
2013-11-13 2013-09-30 13F INTEGRA LIFESCIENCES HLDGS COM 457985208 10,562 -3,026 -22.27 425 -14.66 0.0002
2013-08-08 2013-06-30 13F INTEGRA LIFESCIENCES HLDGS COM 457985208 13,588 13,588 498 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.